)
)
)
Navigating the New Normal: Venture Investment Trends
March 02, 2026
Pompeii Ballroom
Type: Educational Session
HSBC’s mid-year report signaled the challenges that many small and mid-sized biotech companies have shared; first financings declined in Q2 of 2025 and entrepreneurs and companies have had to make tough staffing decisions and adjust their pipelines and programs. While interest rates have started to lower, macroeconomic uncertainties remain in addition to the risk embedded in developing novel medicines. This session will begin with an overview of financing in 2025 followed by a discussion on how companies and investors have remained nimble. The role of venture capital and how family offices are participating in financing will also be featured. Key Takeaways: -Data on where venture investment dollars are going presented by HSBC Innovation -Tips from investors for leaders of biotech companies when seeking funding -Information on how family offices are participating in the ecosystem -Emerging areas of interest in innovation
Moderator
Speakers
.png)
){kind=logo}
)
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
